查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1763901

腹疝氣網片設備市場－全球產業規模、佔有率、趨勢、機會和預測，按網片類型、適應症、手術程序、最終用途、地區和競爭情況細分，2020 年至 2030 年

Ventral Hernia Mesh Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Mesh Type, By Indication, By Procedure, By End Use, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年，全球腹疝氣網片裝置市場價值為8.4106億美元，預計2030年將達到13.7561億美元，預測期內複合年成長率為8.52%。市場成長主要受腹疝氣盛行率不斷上升的驅動，這類疾病通常與肥胖、先前腹部手術史和人口老化有關。這些網片裝置在外科修復中發揮著至關重要的作用，可以加強薄弱的腹壁，降低復發風險。

市場概覽
預測期 2026-2030
2024年市場規模 8.4106億美元
2030年市場規模 13.7561億美元
2025-2030 年複合年成長率 8.52%
成長最快的領域 機器人手術
最大的市場 北美洲

隨著微創手術需求的不斷成長，基於網片的修補術因其改善患者預後和降低併發症發生率而比傳統縫合術更受青睞。醫療保健系統越來越重視更快的恢復速度和長期耐用性，這促進了先進網片產品的廣泛應用。網片設計的創新——例如輕質材料、可吸收材料和複合材料——正在提高生物相容性、手術效率和患者舒適度。隨著患者意識的提升和研發投入的不斷增加，全球腹部疝片設備市場可望持續成長。

關鍵市場促進因素

腹疝氣盛行率上升及相關危險因子

主要市場挑戰

高級網狀設備成本高，限制了可訪問性

主要市場趨勢

輕質複合網狀材料需求不斷成長

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球腹部疝氣網片設備市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依網片類型（可吸收網片、部分可吸收網片、不可吸收網片）
    • 依適應症（臍疝氣、上腹疝氣、切口疝氣、其他）
    • 依手術方式（開放式手術、腹腔鏡手術、機器人手術、其他）
    • 依最終用途（住院設施、門診設施）
    • 按公司分類（2024）
    • 按地區
  • 市場地圖

第6章：北美腹疝氣網片設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第7章：歐洲腹部疝氣網片設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太腹疝氣網片設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲

第9章：南美洲腹疝氣網片設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲腹部疝氣網片設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 合併與收購（如有）
  • 產品發布（如有）
  • 最新動態

第13章：干擾：衝突、流行病與貿易壁壘

第 14 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章：競爭格局

  • Medtronic plc
  • Becton, Dickinson and Company (BD)
  • Meril Life Sciences Pvt. Ltd.
  • Novus Scientific AB
  • B. Braun SE
  • TELA Bio, Inc.
  • BG Medical LLC
  • Integra LifeSciences Corporation
  • WL Gore & Associates, Inc.
  • Atrium Medical

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 29880

The Global Ventral Hernia Mesh Devices Market was valued at USD 841.06 Million in 2024 and is projected to reach USD 1375.61 Million by 2030, growing at a CAGR of 8.52% during the forecast period. The market is driven by a growing prevalence of ventral hernias, often linked to obesity, prior abdominal surgeries, and aging populations. These mesh devices play a crucial role in surgical repairs by reinforcing weakened abdominal walls and reducing the risk of recurrence.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 841.06 Million
Market Size 2030USD 1375.61 Million
CAGR 2025-20308.52%
Fastest Growing SegmentRobotic Surgery
Largest MarketNorth America

As the demand for minimally invasive procedures increases, mesh-based repairs are increasingly preferred over traditional suture methods due to improved patient outcomes and lower complication rates. Healthcare systems are placing greater emphasis on faster recovery and long-term durability, which is contributing to the widespread adoption of advanced mesh products. Innovations in mesh design-such as lightweight, absorbable, and composite materials-are enhancing biocompatibility, surgical efficiency, and patient comfort. With rising awareness among patients and increasing investments in research and development, the global ventral hernia mesh devices market is poised for sustained growth.

Key Market Drivers

Rising Prevalence of Ventral Hernias and Related Risk Factors

The increasing incidence of ventral hernias globally is a primary driver of market growth. In the United States alone, over 350,000 ventral hernia repair procedures are performed annually, underscoring the growing clinical need for effective treatment solutions. Prevalence is notably higher among individuals aged 45 and above, driven by factors such as tissue degeneration and obesity.

With approximately 600,000 repairs performed annually, as reported by the CDC, the demand for durable and reliable mesh devices is intensifying. Obesity-affecting over 40% of U.S. adults-contributes to elevated intra-abdominal pressure, further heightening the risk of hernia development. These statistics reflect a growing and persistent demand for mesh-based repair products that can provide long-term reinforcement and reduce recurrence rates.

Key Market Challenges

High Cost of Advanced Mesh Devices Limiting Accessibility

The high cost associated with advanced ventral hernia mesh products remains a key barrier to wider adoption, especially in low- and middle-income countries. These premium devices-often featuring bioresorbable materials or advanced composites-command elevated prices due to the use of proprietary technologies, strict regulatory requirements, and high production costs.

Hospitals operating under budget constraints and patients lacking robust insurance coverage may struggle to access these advanced solutions. In resource-limited settings, the preference often shifts toward less expensive or traditional repair methods, despite higher risks of complications. Even in developed markets, limited reimbursement for next-generation meshes can discourage surgeons from adopting the latest products, further slowing innovation diffusion and creating disparities in patient outcomes.

Key Market Trends

Rising Demand for Lightweight and Composite Mesh Materials

A notable trend in the ventral hernia mesh market is the shift toward lightweight and composite mesh materials that offer enhanced patient comfort and reduced post-operative complications. Conventional heavyweight meshes have been associated with adverse outcomes such as chronic pain and foreign body sensation.

Modern lightweight meshes, featuring larger pores and reduced material density, allow for better integration with host tissue and lower inflammatory responses. These design improvements contribute to more favorable healing, decreased fibrosis, and enhanced overall patient satisfaction. As surgeons seek safer, more effective solutions with fewer long-term risks, the demand for these advanced mesh materials continues to grow across both inpatient and outpatient settings.

Key Market Players

  • Medtronic plc
  • Becton, Dickinson and Company (BD)
  • Meril Life Sciences Pvt. Ltd.
  • Novus Scientific AB
  • B. Braun SE
  • TELA Bio, Inc.
  • BG Medical LLC
  • Integra LifeSciences Corporation
  • W. L. Gore & Associates, Inc.
  • Atrium Medical

Report Scope:

In this report, the Global Ventral Hernia Mesh Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Ventral Hernia Mesh Devices Market, By Mesh Type:

  • Resorbable Mesh
  • Partially Absorbable Mesh
  • Non-Resorbable Mesh

Ventral Hernia Mesh Devices Market, By Indication:

  • Umbilical Hernia
  • Epigastric Hernia
  • Incisional Hernia
  • Others

Ventral Hernia Mesh Devices Market, By Procedure:

  • Open Surgery
  • Laparoscopic Surgery
  • Robotic Surgery
  • Others

Ventral Hernia Mesh Devices Market, By End Use:

  • Inpatient Facilities
  • Outpatient Facilities

Ventral Hernia Mesh Devices Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Ventral Hernia Mesh Devices Market.

Available Customizations:

Global Ventral Hernia Mesh Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Ventral Hernia Mesh Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Mesh Type (Resorbable Mesh, Partially Absorbable Mesh, Non-Resorbable Mesh)
    • 5.2.2. By Indication (Umbilical Hernia, Epigastric Hernia, Incisional Hernia, Others)
    • 5.2.3. By Procedure (Open Surgery, Laparoscopic Surgery, Robotic Surgery, Others)
    • 5.2.4. By End Use (Inpatient Facilities, Outpatient Facilities)
    • 5.2.5. By Company (2024)
    • 5.2.6. By Region
  • 5.3. Market Map

6. North America Ventral Hernia Mesh Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Mesh Type
    • 6.2.2. By Indication
    • 6.2.3. By Procedure
    • 6.2.4. By End Use
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Ventral Hernia Mesh Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Mesh Type
        • 6.3.1.2.2. By Indication
        • 6.3.1.2.3. By Procedure
        • 6.3.1.2.4. By End Use
    • 6.3.2. Mexico Ventral Hernia Mesh Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Mesh Type
        • 6.3.2.2.2. By Indication
        • 6.3.2.2.3. By Procedure
        • 6.3.2.2.4. By End Use
    • 6.3.3. Canada Ventral Hernia Mesh Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Mesh Type
        • 6.3.3.2.2. By Indication
        • 6.3.3.2.3. By Procedure
        • 6.3.3.2.4. By End Use

7. Europe Ventral Hernia Mesh Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Mesh Type
    • 7.2.2. By Indication
    • 7.2.3. By Procedure
    • 7.2.4. By End Use
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Ventral Hernia Mesh Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Mesh Type
        • 7.3.1.2.2. By Indication
        • 7.3.1.2.3. By Procedure
        • 7.3.1.2.4. By End Use
    • 7.3.2. Germany Ventral Hernia Mesh Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Mesh Type
        • 7.3.2.2.2. By Indication
        • 7.3.2.2.3. By Procedure
        • 7.3.2.2.4. By End Use
    • 7.3.3. United Kingdom Ventral Hernia Mesh Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Mesh Type
        • 7.3.3.2.2. By Indication
        • 7.3.3.2.3. By Procedure
        • 7.3.3.2.4. By End Use
    • 7.3.4. Italy Ventral Hernia Mesh Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Mesh Type
        • 7.3.4.2.2. By Indication
        • 7.3.4.2.3. By Procedure
        • 7.3.4.2.4. By End Use
    • 7.3.5. Spain Ventral Hernia Mesh Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Mesh Type
        • 7.3.5.2.2. By Indication
        • 7.3.5.2.3. By Procedure
        • 7.3.5.2.4. By End Use

8. Asia-Pacific Ventral Hernia Mesh Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Mesh Type
    • 8.2.2. By Indication
    • 8.2.3. By Procedure
    • 8.2.4. By End Use
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Ventral Hernia Mesh Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Mesh Type
        • 8.3.1.2.2. By Indication
        • 8.3.1.2.3. By Procedure
        • 8.3.1.2.4. By End Use
    • 8.3.2. India Ventral Hernia Mesh Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Mesh Type
        • 8.3.2.2.2. By Indication
        • 8.3.2.2.3. By Procedure
        • 8.3.2.2.4. By End Use
    • 8.3.3. South Korea Ventral Hernia Mesh Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Mesh Type
        • 8.3.3.2.2. By Indication
        • 8.3.3.2.3. By Procedure
        • 8.3.3.2.4. By End Use
    • 8.3.4. Japan Ventral Hernia Mesh Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Mesh Type
        • 8.3.4.2.2. By Indication
        • 8.3.4.2.3. By Procedure
        • 8.3.4.2.4. By End Use
    • 8.3.5. Australia Ventral Hernia Mesh Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Mesh Type
        • 8.3.5.2.2. By Indication
        • 8.3.5.2.3. By Procedure
        • 8.3.5.2.4. By End Use

9. South America Ventral Hernia Mesh Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Mesh Type
    • 9.2.2. By Indication
    • 9.2.3. By Procedure
    • 9.2.4. By End Use
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Ventral Hernia Mesh Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Mesh Type
        • 9.3.1.2.2. By Indication
        • 9.3.1.2.3. By Procedure
        • 9.3.1.2.4. By End Use
    • 9.3.2. Argentina Ventral Hernia Mesh Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Mesh Type
        • 9.3.2.2.2. By Indication
        • 9.3.2.2.3. By Procedure
        • 9.3.2.2.4. By End Use
    • 9.3.3. Colombia Ventral Hernia Mesh Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Mesh Type
        • 9.3.3.2.2. By Indication
        • 9.3.3.2.3. By Procedure
        • 9.3.3.2.4. By End Use

10. Middle East and Africa Ventral Hernia Mesh Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Mesh Type
    • 10.2.2. By Indication
    • 10.2.3. By Procedure
    • 10.2.4. By End Use
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Ventral Hernia Mesh Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Mesh Type
        • 10.3.1.2.2. By Indication
        • 10.3.1.2.3. By Procedure
        • 10.3.1.2.4. By End Use
    • 10.3.2. Saudi Arabia Ventral Hernia Mesh Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Mesh Type
        • 10.3.2.2.2. By Indication
        • 10.3.2.2.3. By Procedure
        • 10.3.2.2.4. By End Use
    • 10.3.3. UAE Ventral Hernia Mesh Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Mesh Type
        • 10.3.3.2.2. By Indication
        • 10.3.3.2.3. By Procedure
        • 10.3.3.2.4. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Medtronic plc
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Becton, Dickinson and Company (BD)
  • 15.3. Meril Life Sciences Pvt. Ltd.
  • 15.4. Novus Scientific AB
  • 15.5. B. Braun SE
  • 15.6. TELA Bio, Inc.
  • 15.7. BG Medical LLC
  • 15.8. Integra LifeSciences Corporation
  • 15.9. W. L. Gore & Associates, Inc.
  • 15.10. Atrium Medical

16. Strategic Recommendations

17. About Us & Disclaimer